EVO
Price
$4.20
Change
-$0.14 (-3.23%)
Updated
Jul 3 closing price
Capitalization
2.77B
38 days until earnings call
OGI
Price
$1.43
Change
+$0.05 (+3.62%)
Updated
Jul 3 closing price
Capitalization
200.85M
Interact to see
Advertisement

EVO vs OGI

Header iconEVO vs OGI Comparison
Open Charts EVO vs OGIBanner chart's image
Evotec SE
Price$4.20
Change-$0.14 (-3.23%)
Volume$61.99K
Capitalization2.77B
Organigram Global
Price$1.43
Change+$0.05 (+3.62%)
Volume$546.1K
Capitalization200.85M
EVO vs OGI Comparison Chart in %
Loading...
EVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EVO vs. OGI commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVO is a Hold and OGI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (EVO: $4.20 vs. OGI: $1.43)
Brand notoriety: EVO and OGI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EVO: 42% vs. OGI: 97%
Market capitalization -- EVO: $2.77B vs. OGI: $200.85M
EVO [@Pharmaceuticals: Other] is valued at $2.77B. OGI’s [@Pharmaceuticals: Other] market capitalization is $200.85M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVO’s FA Score shows that 1 FA rating(s) are green whileOGI’s FA Score has 0 green FA rating(s).

  • EVO’s FA Score: 1 green, 4 red.
  • OGI’s FA Score: 0 green, 5 red.
According to our system of comparison, OGI is a better buy in the long-term than EVO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVO’s TA Score shows that 6 TA indicator(s) are bullish while OGI’s TA Score has 3 bullish TA indicator(s).

  • EVO’s TA Score: 6 bullish, 4 bearish.
  • OGI’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, EVO is a better buy in the short-term than OGI.

Price Growth

EVO (@Pharmaceuticals: Other) experienced а -0.47% price change this week, while OGI (@Pharmaceuticals: Other) price change was +2.14% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

EVO is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EVO($2.77B) has a higher market cap than OGI($201M). EVO YTD gains are higher at: 0.962 vs. OGI (-11.180). EVO has higher annual earnings (EBITDA): -63.26M vs. OGI (-195.74M). EVO has more cash in the bank: 619M vs. OGI (42.3M). OGI has less debt than EVO: OGI (136K) vs EVO (589M). EVO has higher revenues than OGI: EVO (821M) vs OGI (161M).
EVOOGIEVO / OGI
Capitalization2.77B201M1,378%
EBITDA-63.26M-195.74M32%
Gain YTD0.962-11.180-9%
P/E Ratio476.19N/A-
Revenue821M161M510%
Total Cash619M42.3M1,463%
Total Debt589M136K433,088%
FUNDAMENTALS RATINGS
EVO vs OGI: Fundamental Ratings
EVO
OGI
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
51
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9483
PRICE GROWTH RATING
1..100
5047
P/E GROWTH RATING
1..100
239
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGI's Valuation (51) in the null industry is somewhat better than the same rating for EVO (93). This means that OGI’s stock grew somewhat faster than EVO’s over the last 12 months.

OGI's Profit vs Risk Rating (100) in the null industry is in the same range as EVO (100). This means that OGI’s stock grew similarly to EVO’s over the last 12 months.

OGI's SMR Rating (83) in the null industry is in the same range as EVO (94). This means that OGI’s stock grew similarly to EVO’s over the last 12 months.

OGI's Price Growth Rating (47) in the null industry is in the same range as EVO (50). This means that OGI’s stock grew similarly to EVO’s over the last 12 months.

EVO's P/E Growth Rating (2) in the null industry is somewhat better than the same rating for OGI (39). This means that EVO’s stock grew somewhat faster than OGI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EVOOGI
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
72%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
68%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 17 days ago
80%
Bearish Trend 17 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
64%
Bullish Trend 4 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
EVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSCDF5.750.50
+9.54%
Tesco PLC
CNGA0.07N/A
N/A
Conair Corp.
SEPJF53.40N/A
N/A
Spectris Plc.
ESTTF5682155.00N/A
N/A
Estore Corp.
BQSSF2.84-0.19
-6.27%
Boss Energy Ltd

EVO and

Correlation & Price change

A.I.dvisor tells us that EVO and OGI have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVO and OGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVO
1D Price
Change %
EVO100%
-3.23%
OGI - EVO
26%
Poorly correlated
+3.62%
ESPR - EVO
25%
Poorly correlated
+1.74%
CGC - EVO
24%
Poorly correlated
+7.56%
ACB - EVO
23%
Poorly correlated
+1.57%
ELAN - EVO
22%
Poorly correlated
-0.54%
More

OGI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGI has been loosely correlated with TLRY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if OGI jumps, then TLRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGI
1D Price
Change %
OGI100%
+3.62%
TLRY - OGI
61%
Loosely correlated
+11.03%
ACB - OGI
60%
Loosely correlated
+1.57%
CRON - OGI
59%
Loosely correlated
+2.00%
CGC - OGI
59%
Loosely correlated
+7.56%
HROW - OGI
35%
Loosely correlated
+3.86%
More